Catalyst Wire Dossier Catalyst Wire Dossier

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002)

triciribine phosphate monohydrate · Prescient Therapeutics, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Triciribine Phosphate Monohydrate (TCN-PM, VD-0002), covering 2016-08-09 to 2016-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer [Phase 1]

See pricing